1. 2334 Nab Paclitaxel (Nab-P) and Gemcitabine (G) as first line chemotherapy (CT) in advanced pancreatic cancer (APDAC) patients (pts): An Italian "real life" study. (September 2015) Authors: Giordano, G.; Febbraro, A.; Vaccaro, V.; Zagonel, V.; De Giorgi, U.; Melisi, D.; Vasile, E.; Bianco, R.; Lo Re, G.; Valente, M.; Formica, V.; Montesarchio, V.; Maiorino, L.; Sanna, G.; Bittoni, A.; Ricci, V.; Santini, D.; Zaniboni, A.; Milella, M.; De Vita, F. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S444 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 2335 Analysis of activity, efficacy and safety of first line Nab Paclitaxel (Nab-P) and Gemcitabine (G) in advanced pancreatic cancer (APDAC) frail and elderly patients (pts). (September 2015) Authors: Giordano, G.; De Vita, F.; Melisi, D.; Vaccaro, V.; Zaniboni, A.; Zagonel, V.; Vasile, E.; Passardi, A.; Leo, L.; Ventriglia, J.; Marciano, R.; Russano, M.; Conca, R.; Andreozzi, F.; Lucchini, E.; Musettini, G.; Bertocchi, P.; Bergamo, F.; Milella, M.; Febbraro, A. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S445 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Efficacy and safety of Everolimus and Exemestane in hormone-receptor positive (HR+) human-epidermal-growth-factor negative (HER2−) advanced breast cancer patients: New insights beyond clinical trials. The EVA study. (October 2017) Authors: Alù, M.; Ancona, C.; Andreis, D.; Bajardi, E.; Benedetto, C.; Berardi, R.; Bordin, E.; Butti, C.; Capri, G.; Cicchiello, F.; Cocciolone, V.; Dester, M.; D'Onofrio, L.; Febbraro, A.; Ferrarini, I.; Fotia, V.; Gervasi, E.; Guaitoli, G.; Licata, L.; Liscia, N. Journal: Breast Issue: Volume 35(2017) Page Start: 115 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Metronomic chemotherapy for advanced breast cancer patients in the real world practice: Final results of the VICTOR-6 study. (December 2019) Authors: Cazzaniga, M.E.; Pinotti, G.; Montagna, E.; Amoroso, D.; Berardi, R.; Butera, A.; Cagossi, K.; Cavanna, L.; Ciccarese, M.; Cinieri, S.; Cretella, E.; De Conciliis, E.; Febbraro, A.; Ferraù, F.; Ferzi, A.; Fiorentini, G.; Fontana, A.; Gambaro, A.R.; Garrone, O.; Gebbia, V. Journal: Breast Issue: Volume 48(2019) Page Start: 7 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Microwave ablation with AMICA® probe for unresectable locally advanced pancreatic cancer. Quality of life and performance status. Issue 1 (January 2015) Authors: Sciascia, V.; Febbraro, A.; Benincasa, G.; Di Gaeta, E.; Perillo, G.; Marra, D.M.; Festa, L.; Pascale, L.; Ambrosino, G. Journal: European journal of surgical oncology Issue: Volume 41:Issue 1(2015:Jan.) Page Start: S3 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Nab paclitaxel (Nab-P) and gemcitabine (G) first line chemotherapy (CT) in metastatic pancreatic cancer (mPC) patients (pts) relapsed after adjuvant treatment (ADJ T): A "real life" study. (February 2017) Authors: Giordano, G.; Lo Re, G.; Milella, M.; Di Marco, M.; Melisi, D.; Passardi, A.; Iop, A.; Febbraro, A.; Foltran, L.; Francesca, B.; Bertocchi, P.; Vaccaro, V.; Aloi, M.B.; Giommoni, E.; Ricci, V.; Vasile, E.; Zaniboni, A.; Zagone, V.; De Vita, F. Journal: European journal of cancer Issue: Volume 72(2017)Supplement 1 Page Start: S87 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗